Systemic davunetide provides sex-specific neuroprotection during Coronary Artery Bypass Grafting (CABG).

Figure 3F at the individual level, strengthens the men and women differences while showing an extremely significant correlation in the AL-208 group, R = 0.8268, ***P = 0.000078 between the change from baseline at 6- and 24-h extracorporeal circulation, the placebo group showed a more moderate correlation with time R = 0.6341, P = 0.0199.

also in 2,465 other papers